您的购物车当前为空
别名 阿汀昔替尼
Atinvicitinib 是一种选择性 Janus 激酶 (JAK) 抑制剂,对 JAK1 具有高度特异性,抑制依赖 JAK1 酶活性的下游细胞因子信号通路。Atinvicitinib 可调控多种与瘙痒反应、过敏及炎症相关的细胞因子,是研究细胞因子介导免疫过程及过敏与炎症疾病调控的重要工具。


为众多的药物研发团队赋能,
让新药发现更简单!
Atinvicitinib 是一种选择性 Janus 激酶 (JAK) 抑制剂,对 JAK1 具有高度特异性,抑制依赖 JAK1 酶活性的下游细胞因子信号通路。Atinvicitinib 可调控多种与瘙痒反应、过敏及炎症相关的细胞因子,是研究细胞因子介导免疫过程及过敏与炎症疾病调控的重要工具。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,490 | In stock | |
| 5 mg | ¥ 3,730 | In stock | |
| 10 mg | ¥ 5,320 | In stock | |
| 25 mg | ¥ 7,850 | In stock | |
| 50 mg | ¥ 10,800 | In stock | |
| 100 mg | ¥ 14,500 | In stock | |
| 200 mg | ¥ 19,600 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,950 | In stock |
Atinvicitinib 相关产品
| 产品描述 | Atinvicitinib, a selective Janus kinase (JAK) inhibitor, demonstrates high specificity for Janus kinase 1 (JAK1), consequently inhibiting downstream cytokine signaling pathways that rely on JAK1 enzymatic activity. Atinvicitinib modulates a wide range of cytokines that are implicated in itch responses, allergic reactions, and inflammatory conditions, making it a significant research tool for studying cytokine-mediated immune processes as well as therapeutic modulation of allergic and inflammatory diseases. |
| 别名 | 阿汀昔替尼 |
| 分子量 | 360.35 |
| 分子式 | C16H17FN6O3 |
| CAS No. | 2169273-59-8 |
| Smiles | COc1cc(Nc2nn(cc2C(N)=O)[C@H]2COCC[C@@H]2C#N)cc(F)n1 |
| 密度 | 1.53 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (222.01 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (9.16 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容